David Rennison

1.5k total citations
50 papers, 1.3k citations indexed

About

David Rennison is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, David Rennison has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 17 papers in Cellular and Molecular Neuroscience and 13 papers in Organic Chemistry. Recurrent topics in David Rennison's work include Neuroscience and Neuropharmacology Research (11 papers), Antimicrobial Peptides and Activities (7 papers) and Synthesis and biological activity (6 papers). David Rennison is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Antimicrobial Peptides and Activities (7 papers) and Synthesis and biological activity (6 papers). David Rennison collaborates with scholars based in New Zealand, Italy and United Kingdom. David Rennison's co-authors include Alan T. McGown, Nicholas J. Lawrence, John A. Hadfield, Sylvie Ducki, Margaret A. Brimble, Jérémie Fournier Dit Chabert, Johan Svenson, Brian Hopkins, Sergio Bova and John S. Svendsen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Accounts of Chemical Research and PLoS ONE.

In The Last Decade

David Rennison

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Rennison New Zealand 15 732 489 231 95 75 50 1.3k
Tomasz Plech Poland 26 967 1.3× 664 1.4× 188 0.8× 96 1.0× 40 0.5× 113 2.0k
Jolanta Solecka Poland 21 577 0.8× 380 0.8× 227 1.0× 21 0.2× 24 0.3× 58 1.2k
Nilantha Sirisoma United States 19 700 1.0× 997 2.0× 233 1.0× 57 0.6× 54 0.7× 24 1.9k
Kimiko Hashimoto Japan 23 747 1.0× 548 1.1× 360 1.6× 96 1.0× 45 0.6× 70 1.4k
Karen L. Erickson United States 25 648 0.9× 606 1.2× 262 1.1× 53 0.6× 31 0.4× 78 1.8k
Alessandra Mascarello Brazil 23 594 0.8× 631 1.3× 152 0.7× 26 0.3× 83 1.1× 57 1.4k
Zoltán Kele Hungary 22 162 0.2× 687 1.4× 115 0.5× 99 1.0× 26 0.3× 93 1.4k
Monika Wujec Poland 24 1.4k 2.0× 604 1.2× 102 0.4× 56 0.6× 78 1.0× 130 1.9k
Natalia V. Sumbatyan Russia 17 193 0.3× 783 1.6× 144 0.6× 75 0.8× 45 0.6× 48 1.4k
Dong Yang United States 24 412 0.6× 1.1k 2.2× 822 3.6× 102 1.1× 73 1.0× 94 1.9k

Countries citing papers authored by David Rennison

Since Specialization
Citations

This map shows the geographic impact of David Rennison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Rennison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Rennison more than expected).

Fields of papers citing papers by David Rennison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Rennison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Rennison. The network helps show where David Rennison may publish in the future.

Co-authorship network of co-authors of David Rennison

This figure shows the co-authorship network connecting the top 25 collaborators of David Rennison. A scholar is included among the top collaborators of David Rennison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Rennison. David Rennison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mros, Sonya, Scott Ferguson, Gregory M. Cook, et al.. (2025). Beyond the “2 + 2 Pharmacophore” Electronic and Hydrophobic Effects Control the Activity of Cationic Amphiphilic Antimicrobial 2,5-Diketopiperazines. Journal of Medicinal Chemistry. 68(21). 22484–22506.
2.
Cahill, Patrick, David Rennison, Olivier Champeau, et al.. (2023). Nature-Inspired Peptide Antifouling Biocide: Coating Compatibility, Field Validation, and Environmental Stability. ACS Applied Bio Materials. 6(6). 2415–2425. 7 indexed citations
3.
Ferrari, Mauro, Claudio D’Amore, Sergio Bova, et al.. (2022). Nitrobenzoxadiazole derivatives of the rat selective toxicant norbormide as fluorescent probes for live cell imaging. Bioorganic & Medicinal Chemistry. 59. 116670–116670. 3 indexed citations
4.
Davison, Emma K., John E. McGowan, Sonya Mros, et al.. (2020). C-2 derivatized 8-sulfonamidoquinolines as antibacterial compounds. Bioorganic & Medicinal Chemistry. 29. 115837–115837. 3 indexed citations
5.
McGowan, John E., Emma K. Davison, Sonya Mros, et al.. (2020). Substituted sulfonamide bioisosteres of 8-hydroxyquinoline as zinc-dependent antibacterial compounds. Bioorganic & Medicinal Chemistry Letters. 30(11). 127110–127110. 9 indexed citations
6.
Ferguson, Scott, Chen‐Yi Cheung, Michelle McConnell, et al.. (2019). Microtiter Screening Reveals Oxygen-Dependent Antimicrobial Activity of Natural Products Against Mastitis-Causing Bacteria. Frontiers in Microbiology. 10. 1995–1995. 5 indexed citations
7.
Saponara, Simona, Fabio Fusi, Ottavia Spiga, et al.. (2019). The Selective Rat Toxicant Norbormide Blocks KATP Channels in Smooth Muscle Cells But Not in Insulin-Secreting Cells. Frontiers in Pharmacology. 10. 598–598. 7 indexed citations
8.
D’Amore, Claudio, Genny Orso, Fabio Fusi, et al.. (2016). An NBD Derivative of the Selective Rat Toxicant Norbormide as a New Probe for Living Cell Imaging. Frontiers in Pharmacology. 7. 315–315. 10 indexed citations
9.
Conole, Daniel, et al.. (2014). Synthesis and methemoglobinemia-inducing properties of benzocaine isosteres designed as humane rodenticides. Bioorganic & Medicinal Chemistry. 22(7). 2220–2235. 29 indexed citations
10.
Rennison, David, et al.. (2013). Synthesis and methemoglobinemia-inducing properties of analogues of para-aminopropiophenone designed as humane rodenticides. Bioorganic & Medicinal Chemistry Letters. 23(24). 6629–6635. 14 indexed citations
11.
Rennison, David, Daniel Conole, Sergio Bova, et al.. (2013). Prodrugs of N-dicarboximide derivatives of the rat selective toxicant norbormide. Bioorganic & Medicinal Chemistry. 21(18). 5886–5899. 13 indexed citations
12.
Rennison, David, Sergio Bova, Maurizio Cavalli, et al.. (2012). Design and synthesis of prodrugs of the rat selective toxicant norbormide. Bioorganic & Medicinal Chemistry. 20(13). 3997–4011. 15 indexed citations
13.
Ducki, Sylvie, et al.. (2009). Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: Synthesis and biological evaluation of antivascular activity. Bioorganic & Medicinal Chemistry. 17(22). 7698–7710. 166 indexed citations
14.
Hopkins, Brian, et al.. (2008). In vitro metabolism of norbormide in rat, mouse and guinea pig liver preparations. Environmental Toxicology and Pharmacology. 27(1). 144–148. 2 indexed citations
15.
Rennison, David, Sergio Bova, Maurizio Cavalli, et al.. (2007). Synthesis and activity studies of analogues of the rat selective toxicant norbormide. Bioorganic & Medicinal Chemistry. 15(8). 2963–2974. 31 indexed citations
16.
Zulian, Alessandra, Valeria Petronilli, Sergio Bova, et al.. (2007). Assessing the molecular basis for rat-selective induction of the mitochondrial permeability transition by norbormide. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1767(7). 980–988. 7 indexed citations
17.
Steel, Peter J., Margaret A. Brimble, Brian Hopkins, & David Rennison. (2004). Two stereoisomers of the rat toxicant norbormide. Acta Crystallographica Section C Crystal Structure Communications. 60(5). o374–o376. 4 indexed citations
18.
Lawrence, Nicholas J., David Rennison, Alan T. McGown, & John A. Hadfield. (2003). The total synthesis of an aurone isolated from Uvaria hamiltonii: aurones and flavones as anticancer agents. Bioorganic & Medicinal Chemistry Letters. 13(21). 3759–3763. 112 indexed citations
19.
Lawrence, Nicholas J., et al.. (2001). Antimitotic and cell growth inhibitory properties of combretastatin A-4-like ethers. Bioorganic & Medicinal Chemistry Letters. 11(1). 51–54. 45 indexed citations
20.
Ducki, Sylvie, et al.. (1998). Potent antimitotic and cell growth inhibitory properties of substituted chalcones. Bioorganic & Medicinal Chemistry Letters. 8(9). 1051–1056. 323 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomasz Plech Breakdown of academic impact, for papers by Jolanta Solecka Breakdown of academic impact, for papers by Nilantha Sirisoma Breakdown of academic impact, for papers by Kimiko Hashimoto Breakdown of academic impact, for papers by Karen L. Erickson Breakdown of academic impact, for papers by Alessandra Mascarello Breakdown of academic impact, for papers by Zoltán Kele Breakdown of academic impact, for papers by Monika Wujec Breakdown of academic impact, for papers by Natalia V. Sumbatyan Breakdown of academic impact, for papers by Dong Yang
Rankless by CCL
2026